date,title,source
Oct-18-18,"Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018",GlobeNewswire
Oct-19-18,Agios Rides on Tibsovo Approval Amid Reliance on Celgene,Zacks
Nov-01-18,Edited Transcript of AGIO earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,"Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting,GlobeNewswire
Nov-01-18,Agios Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Incyte,ACCESSWIRE
Nov-01-18,Agios Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-08-18,"New Research Coverage Highlights John B. Sanfilippo & Son, Axcelis Technologies, Cogent Communications, Star Bulk Carriers, Agios Pharmaceuticals, and MDC Partners  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-08-18,3 Biotech Stocks Poised for Big Rebounds,Investopedia
Nov-14-18,Today's Research Reports on Trending Tickers: Exelixis and Agios Pharmaceuticals,ACCESSWIRE
Nov-16-18,Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma,GlobeNewswire
Nov-19-18,Edited Transcript of AGIO earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-26-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Amarin Corporation,ACCESSWIRE
Dec-03-18,Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS),GlobeNewswire
Dec-03-18,Agios Announces Updated Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Standard Induction and Consolidation Chemotherapy in Newly Diagnosed AML Patients With an IDH Mutation,GlobeNewswire
Dec-03-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Exelixis,ACCESSWIRE
Dec-07-18,Today's Research Reports on Trending Tickers: Amarin Corporation and Agios Pharmaceuticals,ACCESSWIRE
Dec-12-18,Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Agios Pharmaceuticals,ACCESSWIRE
Dec-13-18,"Market Trends Toward New Normal in DXC Technology, Patterson Companies, Lumentum, DSW, Agios Pharmaceuticals, and Six Flags Entertainment Corporation New  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-13-18,Hedge Funds Are Selling Agios Pharmaceuticals Inc (AGIO),Insider Monkey
Dec-14-18,"Our Take On Agios Pharmaceuticals, Inc.s (NASDAQ:AGIO) CEO Salary",Simply Wall St.
Dec-28-18,"Agios to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019",GlobeNewswire
Jan-07-19,Agios Highlights Key 2019 Initiatives to Broaden Potential for Cancer and Rare Genetic Disease Programs to Build Long-Term Value,GlobeNewswire
Jan-10-19,5 Biotech Stocks That Could Face M&A Next!,InvestorPlace
Jan-29-19,"Have Insiders Been Selling Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares?",Simply Wall St.
Feb-07-19,Agios Pharmaceuticals (AGIO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Feb-11-19,Agios ex-CEO joins GV as life sciences investment team's co-head,American City Business Journals
Feb-14-19,Agios Pharmaceuticals Inc (AGIO) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-14-19,"Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates",Zacks
Feb-14-19,Agios Pharmaceuticals: 4Q Earnings Snapshot,Associated Press
Feb-14-19,Agios Reports Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Feb-15-19,"Agios (AGIO) Q4 Earnings Beat, Tibsovo Sales Push Up Stock",Zacks
Feb-20-19,Edited Transcript of AGIO earnings conference call or presentation 14-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-21-19,Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer,Zacks
Feb-21-19,"Agios to Present at the Leerink Global Healthcare Conference on Thursday, February 28, 2019",GlobeNewswire
Feb-22-19,"Analysis: Positioning to Benefit within Quest Diagnostics, Autodesk, Agios Pharmaceuticals, AMN Healthcare Services, Vistra Energy, and Helen of Troy  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Feb-25-19,Agios Reports Updated Data from Phase 1 Study of Ivosidenib in Combination with Azacitidine Demonstrating Deep and Durable Responses in Newly Diagnosed IDH1 Mutant Acute Myeloid Leukemia (AML) Patients,GlobeNewswire
Mar-04-19,"Agios to Present at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019",GlobeNewswire
Mar-06-19,"All You Need To Know About Agios Pharmaceuticals, Inc.s (NASDAQ:AGIO) Financial Health",Simply Wall St.
Mar-27-19,Agios (AGIO) Surges More Than 40% Year to Date: Here's Why,Zacks
Mar-27-19,Agios Gains Breakthrough Therapy Status for Tibsovo Combo,Zacks
Apr-02-19,Agios Announces New Commercial Leadership Structure,GlobeNewswire
Apr-02-19,"AVEO Reports Positive Results on Leukemia Drug, Shares Up",Zacks
Apr-11-19,"What Are Analysts Saying About Agios Pharmaceuticals, Inc.'s (NASDAQ:AGIO) Earnings Outlook?",Simply Wall St.
Apr-25-19,"Agios to Webcast Conference Call of First Quarter 2019 Financial Results on May 2, 2019",GlobeNewswire
Apr-26-19,Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline,Zacks
May-02-19,Agios Pharmaceuticals Inc (AGIO) Q1 2019 Earnings Call Transcript,Motley Fool
May-03-19,Agios (AGIO) Earnings and Revenues Surpass Estimates in Q1,Zacks
May-09-19,Edited Transcript of AGIO earnings conference call or presentation 2-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-15-19,"Stocks making the biggest moves after hours: Agios, Farfetch, Cisco and more",CNBC
May-15-19,Agios to Present Clinical Data from its IDH Program at ASCO,GlobeNewswire
May-16-19,Agios' Tibsovo Meets Endpoint in Cholangiocarcinoma Study,Zacks
May-16-19,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",Benzinga
Jun-05-19,"Agios Announces the Planned Retirement of Chief Scientific Officer, Scott Biller, Ph.D., Effective December 31, 2019",GlobeNewswire
Jun-06-19,Life sciences VC firm Third Rock raises $770M in its largest round ever,American City Business Journals
Jun-10-19,"Agios to Present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019",GlobeNewswire
Jun-14-19,Is Agios Pharmaceuticals Inc (AGIO) Going to Burn These Hedge Funds?,Insider Monkey
